As of February 2026 Dermapharm has a market cap of A$3.47 Billion. This makes Dermapharm the world's 4394th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.